Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 77.66
(-1.03%)
CNY 77.66
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 317.56 Million | 286.26 Million | 306.95 Million | 122.15 Million | 74.08 Million | 44 Million |
| Net Income | 240.03 Million | 211.68 Million | 209.1 Million | 93.46 Million | 29.51 Million | 9 Million |
| Depreciation & Amortization | 91.06 Million | 74.37 Million | 67.28 Million | 45.5 Million | 40.55 Million | 35.84 Million |
| Deferred income taxes | 735.68 Thousand | -5.61 Million | -2.59 Million | -469.46 Thousand | -7.55 Million | -215.48 Thousand |
| Stock-based compensation | 23.42 Million | 39.95 Million | 13.31 Million | 4.18 Million | 8.91 Million | 1.48 Million |
| Change in working capital | -53.26 Million | -53.96 Million | 9.45 Million | -34.3 Million | -17.2 Million | -11.07 Million |
| Other non-cash items | 15.58 Million | 48.78 Million | 10.38 Million | 13.77 Million | 19.84 Million | 10.23 Million |
| Investing Cash Flow | -261.94 Million | -299.15 Million | -202.01 Million | -108.14 Million | -69.94 Million | -45.08 Million |
| Investments in PPE | -261.96 Million | -299.22 Million | -95.05 Million | -108.15 Million | -69.97 Million | -45.28 Million |
| Acquisitions | 21.23 Thousand | 76.75 Thousand | 1.25 Million | 4530.97 | 1.93 Million | 10.89 Million |
| Investment purchases | - | - | -130.47 Million | - | - | - |
| Sales/Maturities of investments | - | - | 237.16 Thousand | - | - | - |
| Other Investing Activities | 1.00 | 0.85 | 22.02 Million | -108.15 Million | -1.89 Million | 199.1 Thousand |
| Financing Cash Flow | -84.16 Million | -158.42 Million | 538.12 Million | -15.07 Million | 5.78 Million | 7.22 Million |
| Debt repayment | -70 Million | -120 Million | -80 Million | -130 Million | -103 Million | -80 Million |
| Dividends payments | -177.11 Million | -79.28 Million | -41.17 Million | -10.3 Million | -20 Million | -22.87 Million |
| Common Stock Repurchased | - | - | -272.24 Thousand | -536.18 Thousand | - | - |
| Common Stock Issuance | - | - | 272.24 Thousand | 536.17 Thousand | - | - |
| Other Financing Activities | 30.61 Million | 42.41 Million | 665.25 Million | 131.11 Million | 133.24 Million | 110.1 Million |
| Accounts receivables | -104.38 Million | -37.51 Million | -33.42 Million | -61.27 Million | -47.04 Million | -19.33 Million |
| Accounts payables | 73.16 Million | 23.51 Million | 73.27 Million | 18.72 Million | 63.07 Million | 12.1 Million |
| Inventory | -22.04 Million | -34.34 Million | -27.8 Million | 8.71 Million | -25.67 Million | -3.62 Million |
| Other working capital | 23.42 Million | -5.61 Million | -2.59 Million | -469.46 Thousand | -7.55 Million | -7.45 Million |
| Cash at beginning of period | 515.44 Million | 680.16 Million | 37.21 Million | 38.3 Million | 28.37 Million | 22.28 Million |
| Cash at end of period | 480.41 Million | 508.75 Million | 680.16 Million | 37.21 Million | 38.3 Million | 28.37 Million |
| Capital Expenditure | -261.96 Million | -299.22 Million | -95.05 Million | -108.15 Million | -69.97 Million | -45.28 Million |
| Effect of forex changes on cash | 200.02 Thousand | -89.62 Thousand | -125.02 Thousand | -22.54 Thousand | 11.12 Thousand | -66.2 Thousand |
| Net cash flow / Change in cash | -35.03 Million | -171.4 Million | 642.94 Million | -1.08 Million | 9.93 Million | 6.08 Million |
| Free Cash Flow | 55.6 Million | -12.96 Million | 211.9 Million | 14 Million | 4.1 Million | -1.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 121.44 Million | 134.57 Million | 34.74 Million | 240.03 Million | 57.7 Million | 94.57 Million |
| Depreciation & Amortization | - | 26.32 Million | 26.32 Million | 91.06 Million | 23.69 Million | -40.52 Million |
| Deferred income taxes | - | - | - | 735.68 Thousand | 32.2 Million | -3.51 Million |
| Stock-based compensation | - | - | - | 23.42 Million | 23.42 Million | -13.89 Million |
| Change in working capital | - | - | - | -53.26 Million | -103.01 Million | 57.93 Million |
| Other non-cash items | 47.48 Million | -31.27 Million | 48.68 Million | 15.58 Million | 57.62 Million | 27.47 Million |
| Investing Cash Flow | -32.44 Million | -56.35 Million | -25.34 Million | -261.94 Million | -73.36 Million | -44.38 Million |
| Investments in PPE | -32.51 Million | -46.35 Million | -25.34 Million | -261.96 Million | -73.39 Million | -44.38 Million |
| Acquisitions | 70.86 Thousand | - | - | 21.23 Thousand | 21.23 Thousand | - |
| Investment purchases | - | -10 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -10 Million | - | 1.00 | 1.00 | - |
| Financing Cash Flow | -24.09 Million | -223.71 Million | 29.21 Million | -84.16 Million | 36.74 Million | -83.89 Million |
| Debt repayment | -20 Million | -150 Million | -30 Million | -70 Million | -20 Million | - |
| Dividends payments | - | -375.31 Million | -576.2 Thousand | -177.11 Million | -177.11 Million | -89.02 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.09 Million | -370.89 Million | -785.29 Thousand | 30.61 Million | 201.52 Million | 5.13 Million |
| Accounts receivables | - | - | - | -104.38 Million | -104.38 Million | 57.63 Million |
| Accounts payables | - | - | - | 73.16 Million | - | 13.89 Million |
| Inventory | - | - | - | -22.04 Million | -22.04 Million | 296.98 Thousand |
| Other working capital | - | - | - | 23.42 Million | 23.42 Million | -13.89 Million |
| Cash at beginning of period | 390.97 Million | 567.85 Million | 480.41 Million | 515.44 Million | 425.35 Million | 431.47 Million |
| Cash at end of period | 503.3 Million | 390.97 Million | 567.85 Million | 480.41 Million | 480.41 Million | 425.35 Million |
| Capital Expenditure | -32.51 Million | -46.35 Million | -25.34 Million | -261.96 Million | -73.39 Million | -44.38 Million |
| Effect of forex changes on cash | - | -117.44 Thousand | 124.57 Thousand | 200.02 Thousand | 53.92 Thousand | 97.58 Thousand |
| Net cash flow / Change in cash | 112.33 Million | -176.88 Million | 87.43 Million | -35.03 Million | 55.06 Million | -6.12 Million |
| Free Cash Flow | 136.41 Million | 56.94 Million | 58.09 Million | 55.6 Million | 18.24 Million | 77.67 Million |
SNOA
5206
MFC-PC
DSNY
RLLVF
LSRG